Immatics IMTX
NASDAQ IMTX
$9.56 +0.10 (+1.06%)
As of: Sep 4, 2026 · 3:59 PM EDT

Immatics (IMTX) Retained Earnings (2019 - 2026)

Immatics (IMTX) posted Retained Earnings of -$10.0 million for Q4 2025, down 5.53% sequentially from -$9.5 million in Q3 2025, and down 1007.8% YoY from $1.1 million in Q4 2024.

Analysis

Immatics (IMTX) Retained Earnings (2019 - 2026) Analysis & Trends

Immatics has reported Retained Earnings for 7 years, with the latest figure at -$10.0 million in Q4 2025.

  • Quarterly Retained Earnings fell 1007.8% year-over-year to -$10.0 million in Q4 2025, while the trailing twelve-month figure through Dec 2025 was -$10.0 million (down 1007.8% YoY) and the FY2025 annual result came in at -$9.7 million, down 969.92% from the prior year.
  • Retained Earnings slipped to -$10.0 million in Q4 2025 per IMTX's latest filing, from -$9.5 million in the prior quarter.
  • Over five years, Retained Earnings peaked at $1.1 million in Q4 2024 and troughed at -$692.2 million in Q3 2024.
  • A 5-year average of -$161.1 million and a median of -$5.7 million in 2021 frame the typical range for Retained Earnings.
  • The widest YoY moves for Retained Earnings: up 162.59% in 2024, down 89207.76% in 2024.
  • Over 5 years, Retained Earnings stood at -$615.2 million in 2021, then advanced by 15.41% to -$520.4 million in 2022, then jumped by 99.66% to -$1.8 million in 2023, then jumped by 162.59% to $1.1 million in 2024, then plunged by 1007.8% to -$10.0 million in 2025.
  • According to Business Quant data, Retained Earnings over the past three periods registered -$10.0 million, -$9.5 million, and -$8.5 million for Q4 2025, Q3 2025, and Q2 2025 respectively.
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Retained Earnings (Qtr)
1 Vertex Pharmaceuticals 138.47 Bn 130.62 Bn 2.84 Bn 15.69 Bn
2 Regeneron Pharmaceuticals 85.18 Bn 77.19 Bn 3.93 Bn 37.62 Bn
3 Argenx Se 63.38 Bn 58.19 Bn 1.37 Bn 558.00 Mn
4 Moderna 58.09 Bn 52.95 Bn 52.00 Mn 5.10 Bn
5 Revolution Medicines 44.33 Bn 44.33 Bn - -4.00 Bn
6 BeOne Medicines 40.02 Bn 34.92 Bn 1.53 Bn 13.05 Bn
7 Alnylam Pharmaceuticals 35.57 Bn 32.27 Bn 992.69 Mn -6.33 Bn
8 Royalty Pharma 28.45 Bn 27.61 Bn - 4.38 Bn
9 Insmed 27.48 Bn 26.32 Bn 358.27 Mn 6.57 Bn
10 Immatics 1.17 Bn 711.21 Mn - -1.05 Bn
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2026 -1.05 Bn
Mar 31, 2026 -987.88 Mn
Dec 31, 2025 -914.92 Mn
Sep 30, 2025 -877.13 Mn
Jun 30, 2025 -792.08 Mn
Mar 31, 2025 -662.05 Mn
Dec 31, 2024 -629.98 Mn
Sep 30, 2024 -692.20 Mn
Jun 30, 2024 -673.05 Mn
Mar 31, 2024 -659.42 Mn
Dec 31, 2023 -650.68 Mn
Sep 30, 2023 -621.74 Mn
Jun 30, 2023 -593.09 Mn
Mar 31, 2023 -558.19 Mn
Dec 31, 2022 -520.44 Mn
Sep 30, 2022 -491.10 Mn
Jun 30, 2022 -497.39 Mn
Mar 31, 2022 -507.47 Mn
Dec 31, 2021 -615.24 Mn
Sep 30, 2021 -614.44 Mn